本文關(guān)鍵詞： 原發(fā)性膽汁性肝硬化 健脾補腎活血湯 中西醫(yī)結(jié)合療法　出處：《遼寧中醫(yī)雜志》2008年03期 　論文類型：期刊論文

【摘要】：目的:觀察中西醫(yī)結(jié)合治療原發(fā)性膽汁性肝硬化的臨床療效。方法:將54例原發(fā)性膽汁性肝硬化患者隨機分為兩組,對照組26例口服熊去氧膽酸(優(yōu)思弗)治療;治療組28例在對照組的基礎(chǔ)上加服中藥健脾補腎活血湯治療,觀察治療前后臨床癥狀、生化指標(biāo)以及影像學(xué)變化情況。結(jié)果:治療組在臨床癥狀的緩解、生化指標(biāo)的改善及總有效率等方面均明顯優(yōu)于對照組,差別有顯著性意義(P0.05);結(jié)論:中西醫(yī)結(jié)合治療原發(fā)性膽汁性肝硬化可顯著提高療效。
[Abstract]:Objective: to observe the clinical effect of integrated traditional Chinese and western medicine in the treatment of primary biliary cirrhosis. Methods: 54 patients with primary biliary cirrhosis were randomly divided into two groups. 26 patients in the control group were treated with ursodeoxycholic acid (Yousifer). 28 cases in the treatment group were treated with Jianpi Bushen Huoxue decoction on the basis of the control group. The clinical symptoms, biochemical indexes and imaging changes were observed before and after treatment. Results: the clinical symptoms were relieved in the treatment group. The improvement of biochemical indexes and the total effective rate were significantly better than those of the control group (P 0.05). Conclusion: treatment of primary biliary cirrhosis with combination of traditional Chinese and western medicine can significantly improve the curative effect.
【作者單位】： 河北省中醫(yī)院
【分類號】：R575.2
【正文快照】： 原發(fā)性膽汁性肝硬化(primary biliary cirrihosis,PBC)是一種累及多個器官的自身免疫性肝病,主要見于中年以上婦女,發(fā)病率(3~5)/10萬,并有逐年上升的趨勢[1],其病程長,臨床表現(xiàn)復(fù)雜多樣,熊去氧膽酸(ursodeoxy cholic acid,UDCA)是有效的治療方法,能延緩患者肝臟組織學(xué)進展,是

【參考文獻】

相關(guān)期刊論文 前1條

1 蘇經(jīng)格;;中藥治療原發(fā)性膽汁性肝硬化20例[J];中醫(yī)雜志;2004年07期

【共引文獻】

相關(guān)期刊論文 前6條

1 程良斌;吳凡;;原發(fā)性膽汁性肝硬化中醫(yī)臨床分析[J];湖北中醫(yī)雜志;2011年02期

2 張廠;李軍祥;金周漢;;原發(fā)性膽汁性肝硬化中醫(yī)藥治療現(xiàn)狀[J];遼寧中醫(yī)藥大學(xué)學(xué)報;2009年05期

3 盧殿強;邵銘;;原發(fā)性膽汁性肝硬化中醫(yī)辨治思路[J];遼寧中醫(yī)藥大學(xué)學(xué)報;2012年01期

4 張寧;羅生強;宮Z，

本文編號：1482664